1. Home
  2. MLYS vs PBH Comparison

MLYS vs PBH Comparison

Compare MLYS & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$25.85

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$47.20

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
PBH
Founded
2019
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
2023
2004

Fundamental Metrics

Financial Performance
Metric
MLYS
PBH
Price
$25.85
$47.20
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
$48.67
★ $75.33
AVG Volume (30 Days)
★ 1.2M
466.5K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.43
N/A
EPS
N/A
★ 0.61
Revenue
N/A
★ $975,777,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.31
P/E Ratio
★ N/A
$76.26
Revenue Growth
N/A
★ 36.77
52 Week Low
$22.30
$42.62
52 Week High
$47.65
$71.07

Technical Indicators

Market Signals
Indicator
MLYS
PBH
Relative Strength Index (RSI) 39.48 44.14
Support Level $22.36 $44.73
Resistance Level $31.36 $49.79
Average True Range (ATR) 1.48 1.51
MACD -0.40 -0.07
Stochastic Oscillator 5.09 47.60

Price Performance

Historical Comparison
MLYS
PBH

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: